Heterozygous mutations of Hh pathway genes result in a full phenotypic spectrum of HPE in humans, but not in mice, suggesting that humans may be more sensitive to the dose of Hh signal 36, 37, thus explaining why only heterozygote WDR11 mutations have been found in the patients. This evidence concerns the gene WDR11 and holoprosencephaly.